Antonio Regalado

Antonio Regalado

Creator
0 followers

Biomedicine editor at MIT Technology Review; covers cutting-edge biotech breakthroughs and their societal impact.

Reversed DNA Life Sparks Ethical Dilemma for Scientists
SocialApr 15, 2026

Reversed DNA Life Sparks Ethical Dilemma for Scientists

Mirror life -- with DNA spiraling the other way -- would have no predators and we'd have no defenses against it. And it raises a familiar question: What should scientists do when they see the shadow of the end of...

By Antonio Regalado
Citizen Scientist Exposes Fraud, Secures $15M Return
SocialApr 6, 2026

Citizen Scientist Exposes Fraud, Secures $15M Return

Remarkable story of an underemployed scientific sleuth, David Shloto, who spend his free time digging into image duplication in Dana Farber papers. He sued for fraud forcing cancer institution to disgorge about $15 mm in NIH grants. Here's his video. https://t.co/wXblELJCdZ

By Antonio Regalado
Aging May Be Evolutionary Program, Not Random Decay
SocialApr 3, 2026

Aging May Be Evolutionary Program, Not Random Decay

Is aging programmable? It implies there IS a program created by evolution, not only accident or entropy. But that's a debate. Here's a paper by business consultant Michael Ringel, on this very topic, with many good citations. https://t.co/fREM4AHnJG

By Antonio Regalado
Debating Brainless Clones as Personal
SocialApr 3, 2026

Debating Brainless Clones as Personal

Are you pro-bodyoid or anti-bodyoid? For the purpose of this poll, a bodyoid is: a newborn clone of you lacking a cortex, a.k.a. a brainless clone, gestated by a paid surrogate. It's organs are a perfect match (isogenic) to you...

By Antonio Regalado
Brainless Clones: Expensive, Unethical, and Scientifically Useless
SocialApr 2, 2026

Brainless Clones: Expensive, Unethical, and Scientifically Useless

This thread explores many interesting aspects of brainless clones. It raises the issue of whether this is even useful (including as animal model) It surfaces the terminology "decorticate" which is what's in the literature.

By Antonio Regalado
R3 Bio's Push for Brainless Human Clones Sparks Ethical Debate
SocialMar 30, 2026

R3 Bio's Push for Brainless Human Clones Sparks Ethical Debate

Here's our story about R3 Bio and the entrepreneur dreaming of brainless human clones. https://t.co/ZJpdffTKNP

By Antonio Regalado
Asexual Clones Accumulate Mutations, Facing Inevitable Extinction
SocialMar 24, 2026

Asexual Clones Accumulate Mutations, Facing Inevitable Extinction

They cloned a mouse and kept cloning. It went 58 generations before it just couldn't "This model predicts that in asexual lineages, deleterious mutations inevitably accumulate, ultimately producing mutational meltdown and extinction."

By Antonio Regalado
Nominate Under‑35 Biotech Trailblazers for 2026 Award
SocialJan 9, 2026

Nominate Under‑35 Biotech Trailblazers for 2026 Award

Do you know an up and coming someone killing it in biotech? If they're under 35 years of age, please nominate them for the 2026 Technology Review 35 Innovators Under 35 Award. (or just email me. address is in bio) https://t.co/90fwj4GjNU

By Antonio Regalado
FDA's Prasad Paradox: Conflicting Strictness on Bespoke Therapies
SocialJan 8, 2026

FDA's Prasad Paradox: Conflicting Strictness on Bespoke Therapies

Predictions for cell therapy and gene therapy in 2026. Most interesting is the "Prasad Paradox", meaning a general state of contradiction at the FDA biologics division around laxness and strictness, including misapplication of the concept of "bespoke" therapies.

By Antonio Regalado